BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 16141422)

  • 1. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
    Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
    Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms.
    Shin HK; Salomone S; Potts EM; Lee SW; Millican E; Noma K; Huang PL; Boas DA; Liao JK; Moskowitz MA; Ayata C
    J Cereb Blood Flow Metab; 2007 May; 27(5):998-1009. PubMed ID: 17033691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
    Yamashita K; Kotani Y; Nakajima Y; Shimazawa M; Yoshimura S; Nakashima S; Iwama T; Hara H
    Brain Res; 2007 Jun; 1154():215-24. PubMed ID: 17482584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.
    Takemoto M; Sun J; Hiroki J; Shimokawa H; Liao JK
    Circulation; 2002 Jul; 106(1):57-62. PubMed ID: 12093770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Rho-kinase (ROCK-1 and ROCK-2) and its substantial role in the contractile activity of the sheep ureter.
    Levent A; Büyükafsar K
    Br J Pharmacol; 2004 Oct; 143(3):431-7. PubMed ID: 15351780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase.
    Eto M; Barandiér C; Rathgeb L; Kozai T; Joch H; Yang Z; Lüscher TF
    Circ Res; 2001 Sep; 89(7):583-90. PubMed ID: 11577023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage.
    Satoh S; Hitomi A; Ikegaki I; Kawasaki K; Nakazono O; Iwasaki M; Mohri M; Asano T
    Brain Res Bull; 2010 Jan; 81(1):191-5. PubMed ID: 19723568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
    Hamid SA; Bower HS; Baxter GF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice.
    Williams J; Bogwu J; Oyekan A
    J Hypertens; 2006 Jul; 24(7):1429-36. PubMed ID: 16794494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
    Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
    J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
    Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection mediated by changes in the endothelial actin cytoskeleton.
    Laufs U; Endres M; Stagliano N; Amin-Hanjani S; Chui DS; Yang SX; Simoncini T; Yamada M; Rabkin E; Allen PG; Huang PL; Böhm M; Schoen FJ; Moskowitz MA; Liao JK
    J Clin Invest; 2000 Jul; 106(1):15-24. PubMed ID: 10880044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil and ozagrel in combination show neuroprotective effects on cerebral infarction after murine middle cerebral artery occlusion.
    Koumura A; Hamanaka J; Kawasaki K; Tsuruma K; Shimazawa M; Hozumi I; Inuzuka T; Hara H
    J Pharmacol Exp Ther; 2011 Jul; 338(1):337-44. PubMed ID: 21493751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.
    Limbourg FP; Huang Z; Plumier JC; Simoncini T; Fujioka M; Tuckermann J; Schütz G; Moskowitz MA; Liao JK
    J Clin Invest; 2002 Dec; 110(11):1729-38. PubMed ID: 12464678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo.
    Yada T; Shimokawa H; Hiramatsu O; Kajita T; Shigeto F; Tanaka E; Shinozaki Y; Mori H; Kiyooka T; Katsura M; Ohkuma S; Goto M; Ogasawara Y; Kajiya F
    J Am Coll Cardiol; 2005 Feb; 45(4):599-607. PubMed ID: 15708710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide does not downregulate Rho-kinase (ROCK-2) expression in rat coronary endothelial cells.
    Tiftik RN; Erol A; Cnar MG; Kubat H; Ark M; Ulker S; Büyükafşar K
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):140-7. PubMed ID: 18287881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
    Satoh S; Utsunomiya T; Tsurui K; Kobayashi T; Ikegaki I; Sasaki Y; Asano T
    Life Sci; 2001 Aug; 69(12):1441-53. PubMed ID: 11531167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.
    Wolfrum S; Dendorfer A; Rikitake Y; Stalker TJ; Gong Y; Scalia R; Dominiak P; Liao JK
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1842-7. PubMed ID: 15319269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
    Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.